Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zackery P Bulman

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Nature Communications|July 14, 2023
Structural insights into the mechanism of overcoming Erm-mediated resistance by macrolides acting together with hygromycin-AChih-Wei Chen, Nadja Leimer, Egor A Syroegin, et al.
The Journal of Antimicrobial Chemotherapy|October 20, 2021
Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniaeYanqin Huang, Amisha P Rana, Eric Wenzler, et al.
Msystems|September 14, 2021
Genomic Features Associated with the Degree of Phenotypic Resistance to Carbapenems in Carbapenem-Resistant Klebsiella pneumoniaeZackery P Bulman, Fiorella Krapp, Nathan B Pincus, et al.
The Journal of Antimicrobial Chemotherapy|December 16, 2020
Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6')-IbDavid A Butler, Amisha P Rana, Fiorella Krapp, et al.
Open Forum Infectious Diseases|January 30, 2020
In Vitro Pharmacodynamic Analyses Help Guide the Treatment of Multidrug-Resistant <i>Enterococcus faecium</i> and Carbapenem-Resistant <i>Enterobacter cloacae</i> Bacteremia in a Liver Transplant PatientEric Wenzler, Maressa Santarossa, Kevin A Meyer, et al.
Antimicrobial Agents and Chemotherapy|December 3, 2014
Evolution of Staphylococcus aureus under vancomycin selective pressure: the role of the small-colony variant phenotypeJustin R Lenhard, Christof von Eiff, Irene S Hong, et al.
Antimicrobial Agents and Chemotherapy|April 29, 2015
Emergence of polymyxin B resistance influences pathogenicity in Pseudomonas aeruginosa mutatorsZackery P Bulman, Mark D Sutton, Neang S Ly, et al.
Pharmacotherapy|January 30, 2015
Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale usePhillip J Bergen, Zackery P Bulman, Sarith Saju, et al.
International Journal of Antimicrobial Agents|February 28, 2018
Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection modelZackery P Bulman, Miao Zhao, Michael J Satlin, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2016
Optimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosaNeang S Ly, Zackery P Bulman, Jürgen B Bulitta, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Nature Communications|July 14, 2023
Structural insights into the mechanism of overcoming Erm-mediated resistance by macrolides acting together with hygromycin-AChih-Wei Chen, Nadja Leimer, Egor A Syroegin, et al.
The Journal of Antimicrobial Chemotherapy|October 20, 2021
Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniaeYanqin Huang, Amisha P Rana, Eric Wenzler, et al.
Msystems|September 14, 2021
Genomic Features Associated with the Degree of Phenotypic Resistance to Carbapenems in Carbapenem-Resistant Klebsiella pneumoniaeZackery P Bulman, Fiorella Krapp, Nathan B Pincus, et al.
The Journal of Antimicrobial Chemotherapy|December 16, 2020
Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6')-IbDavid A Butler, Amisha P Rana, Fiorella Krapp, et al.
Open Forum Infectious Diseases|January 30, 2020
In Vitro Pharmacodynamic Analyses Help Guide the Treatment of Multidrug-Resistant <i>Enterococcus faecium</i> and Carbapenem-Resistant <i>Enterobacter cloacae</i> Bacteremia in a Liver Transplant PatientEric Wenzler, Maressa Santarossa, Kevin A Meyer, et al.
Antimicrobial Agents and Chemotherapy|December 3, 2014
Evolution of Staphylococcus aureus under vancomycin selective pressure: the role of the small-colony variant phenotypeJustin R Lenhard, Christof von Eiff, Irene S Hong, et al.
Antimicrobial Agents and Chemotherapy|April 29, 2015
Emergence of polymyxin B resistance influences pathogenicity in Pseudomonas aeruginosa mutatorsZackery P Bulman, Mark D Sutton, Neang S Ly, et al.
Pharmacotherapy|January 30, 2015
Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale usePhillip J Bergen, Zackery P Bulman, Sarith Saju, et al.
International Journal of Antimicrobial Agents|February 28, 2018
Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection modelZackery P Bulman, Miao Zhao, Michael J Satlin, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2016
Optimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosaNeang S Ly, Zackery P Bulman, Jürgen B Bulitta, et al.
Pageof 6